Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

AbbVie Plans to Hire After Doubling Cambridge R&D Facility

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

With the additional space, AbbVie will hire 15 new employees. Source: BioSpace

Continue ReadingAbbVie Plans to Hire After Doubling Cambridge R&D Facility

3 Best Biotherapeutics Stocks to Buy Right Now

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Sometimes the biggest are also the best. That's the case for biotherapeutics stocks. Source: BioSpace

Continue Reading3 Best Biotherapeutics Stocks to Buy Right Now

Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Alder intends to use the cash to fund the development and commercialization of eptinezumab. Source: BioSpace

Continue ReadingAlder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025

TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie…

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

This Phase 2 trial is a 52-week study evaluating the safety and efficacy of ublituximab at accelerated infusion times as fast as one hour. Source: BioSpace

Continue ReadingTG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie…

Mysterious Biotech Unicorn Moderna Nabs Another $500M, Is Now Worth $7B

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

One can only hope that Moderna Therapeutics can live up to the hype, both scientifically and financially. Source: BioSpace

Continue ReadingMysterious Biotech Unicorn Moderna Nabs Another $500M, Is Now Worth $7B

M&A Chatter Swirls Over Amgen's $70B Cashpile

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Amgen reported its fourth-quarter financials yesterday, but in anticipation of this year's hot merger-and-acquisition market, a lot of focus has been on the company's considerable available cash. Source: BioSpace

Continue ReadingM&A Chatter Swirls Over Amgen's $70B Cashpile

Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace

Continue ReadingTeva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital

3 FDA Decisions to Look Out for in February

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Here is a look at a few important regulatory events scheduled for the month of February. Source: BioSpace

Continue Reading3 FDA Decisions to Look Out for in February

Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace

Continue ReadingNewcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi

Trump's CDC Director Resigns Over Pharma, Tobacco Investments

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Fitzgerald resigns four months after ex-HHS Secretary Price. Source: BioSpace

Continue ReadingTrump's CDC Director Resigns Over Pharma, Tobacco Investments
  • Go to the previous page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.